Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

J Favier, L Amar, AP Gimenez-Roqueplo - Nature Reviews …, 2015 - nature.com
Paragangliomas and phaeochromocytomas are neuroendocrine tumours whose
pathogenesis and progression are very strongly influenced by genetics. A germline mutation …

Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review …

S Han, CH Suh, S Woo, YJ Kim… - Journal of Nuclear …, 2019 - Soc Nuclear Med
We performed a systematic review and metaanalysis of the performance of 68Ga-DOTA–
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …

European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

MS Hofman, WFE Lau, RJ Hicks - Radiographics, 2015 - pubs.rsna.org
Gallium 68 (68Ga) 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)–
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …

Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and …

I Janssen, EM Blanchet, K Adams, CC Chen… - Clinical Cancer …, 2015 - AACR
Purpose: Patients with succinate dehydrogenase subunit B (SDHB) mutation–related
pheochromocytoma/paraganglioma (PHEO/PGL) are at a higher risk for metastatic disease …

68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity

CA Chang, DA Pattison, RW Tothill, G Kong, TJ Akhurst… - Cancer Imaging, 2016 - Springer
Background Pheochromocytomas (PCC) and paragangliomas (PGL) are neuroendocrine
tumours arising from pluripotent neural crest stem cells and are associated with neurons of …

Update on modern management of pheochromocytoma and paraganglioma

JWM Lenders, G Eisenhofer - Endocrinology and …, 2017 - synapse.koreamed.org
Despite all technical progress in modern diagnostic methods and treatment modalities of
pheochromocytoma/paraganglioma, early consideration of the presence of these tumors …

A facile one-pot Mannich reaction for the construction of fluorescent polymeric nanoparticles with aggregation-induced emission feature and their biological imaging

R Jiang, H Liu, M Liu, J Tian, Q Huang, H Huang… - Materials Science and …, 2017 - Elsevier
Multicomponent reactions (MCRs) have recently attracted great attention as one of the most
important tools for the construction of various organic compounds in modern organic …

Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma

G Kong, S Grozinsky-Glasberg… - The Journal of …, 2017 - academic.oup.com
Purpose Treatment options for unresectable paraganglioma (PGL)/pheochromocytoma
(PCC), especially with uncontrolled secondary hypertension (HTN), are limited. Preliminary …

68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI

I Janssen, CC Chen, D Taieb, NJ Patronas… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Pheochromocytomas/paragangliomas overexpress somatostatin receptors, and recent
studies have already shown excellent results in the localization of sympathetic succinate …